If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Regulatory News (SNG)

  • There is currently no data for SNG

Total Voting Rights

31 Oct 2008 09:00

RNS Number : 9595G
Synairgen plc
31 October 2008
 



31 October 2008

Synairgen plc (the "Company")

Total Voting Rights

In accordance with DTR 5.6.1 of the FSA's Disclosure Rules and Transparency Rules (DTR), the total issued share capital of the Company with voting rights is 22,392,308 ordinary shares of 1p each ("Ordinary Shares"). The Company does not hold any Ordinary Shares in Treasury.

The above figure of 22,392,308 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

For further information:

Synairgen plc

John Ward

+44 (0)2380 512800

Teathers Limited

Shaun Dobson/Claes Spang

+44 (0)20 7426 9000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRFKCKQQBDDCKB
Date   Source Headline
4th Sep 20097:00 amRNSDirectorate Changes
4th Sep 20097:00 amRNSUS Patent Granted
2nd Sep 20097:00 amRNSNotice of Results
17th Jul 20093:00 pmRNSHolding(s) in Company
30th Jun 20099:56 amRNSTotal Voting Rights
25th Jun 20092:36 pmRNSHolding(s) in Company
23rd Jun 20097:00 amRNSHolding(s) in Company
15th Jun 200911:06 amRNSSecond Closing of the Fundraising
12th Jun 200911:22 amRNSResult of General Meeting
27th May 20097:00 amRNSFundraising Announcement
1st Apr 20097:00 amRNSPreliminary biomarker data
31st Mar 20097:00 amRNSChange of Adviser
26th Mar 20097:00 amRNSHalf Yearly Results
24th Mar 200911:14 amRNSNotice of Results
17th Mar 20097:00 amRNSProgress update: Clinical Trial - Interferon Beta
13th Nov 200812:15 pmRNSResult of AGM
7th Nov 20083:25 pmRNSChange of NOMAD
31st Oct 20089:00 amRNSTotal Voting Rights
20th Oct 20087:00 amRNSDirector/PDMR Shareholding and Additional Listing
10th Oct 20081:53 pmRNSPosting of 2008 Annual Report
8th Oct 20089:12 amRNSChange of Adviser Name
22nd Sep 20087:00 amRNSResearch Update
4th Aug 200810:00 amRNSDirector/PDMR Shareholding
31st Jul 20087:00 amRNSFinal Results
29th Jul 20087:00 amRNSCommencement of Clinical Tria
14th Jul 200811:48 amRNSNotice of Results
23rd May 20087:00 amRNSPresentation of data at ATS
13th Mar 20087:01 amRNSDirector Shareholding
12th Mar 20087:01 amRNSInterim Results
25th Feb 20087:01 amRNSNotice of Results
11th Feb 20087:01 amRNSPatent Granted
15th Nov 20077:01 amRNSResult of AGM
12th Nov 20078:25 amRNSContract with Alpha Biologics
31st Oct 200712:45 pmRNSDirector/PDMR Shareholding
28th Sep 20077:04 amRNSLicence/ Supply by Rentschler
26th Sep 20077:01 amRNSFinal Results
20th Aug 20077:00 amRNSNotice of Preliminary Results
17th Aug 20071:52 pmRNSAIM Rule 26
16th Aug 20072:54 pmRNSChange of Adviser
28th Jun 20072:30 pmRNSDirector/PDMR Shareholding
12th Jun 20077:02 amRNSResearch Update
20th Mar 20074:12 pmRNSHolding(s) in Company
19th Mar 20077:01 amRNSInterim Results
23rd Feb 20073:16 pmRNSHolding(s) in Company
13th Feb 20074:40 pmRNSNotice of Results
12th Dec 200611:55 amRNSTotal Voting Rights
30th Nov 20063:18 pmRNSDirector/PDMR Shareholding
15th Nov 20067:02 amRNSLicenses novel Peptide
8th Nov 200611:11 amRNSHolding(s) in Company
8th Nov 200610:21 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.